Valproic acid (VPA) therapy in children lowers serum carnitine levels, potentially impacting fatty acid metabolism. However, carnitine deficiency alone does not explain VPA-induced fatal hepatotoxicity.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background: